Cytokinetics, Incorporated — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+1.6% +$23M
$1.42B
Current Assets↓-17.2% -$191M
$917M
Cash & Equivalents↑+29.2% +$28M
$123M
Receivables↑+6.7% +$1M
$18M
Net PPE↑+20.3% +$13M
$79M
Total Liabilities↑+35.6% +$547M
$2.08B
Current Liabilities↑+12.7% +$23M
$202M
Account Payables↑+9.7% +$2M
$22M
Long-Term Debt↑+164.3% +$153M
$246M
Stockholders Equity↓-387.3% -$524M
$-660M
Retained Earnings↓-29.1% -$785M
$-3.49B
Operating Lease ROU Asset↑+1.1% +$821K
$76M
Operating Lease Liability↑+12.9% +$14M
$127M
Gross PP&E↑+22.8% +$24M
$126M
Accumulated Depreciation↑+27.2% +$10M
$47M
Debt Due Y1↑+92.3% +$18M
$38M
Debt Due Y2↑+287.9% +$118M
$159M
Debt Due Y3↓-97.7% -$546M
$13M
Debt Due Y4
$13M
Debt Due Y5
$13M
Debt Due >Y5
$763M
Total Debt Carrying Amount↑+61.3% +$380M
$999M
Contract Asset
—
Contract Liability
—
Contract Liability (Current)
—